Risk Factors for Stroke or Systemic Embolism in Chinese Patients with Non-Valvular Atrial Fibrillation Registry

Recruiting Observational Study
Atrial Fibrillation Stroke
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 120
Sex
Any
Study type
Observational
Participants needed
22,000 (estimated)
Sponsor
China National Center for Cardiovascular Diseases · Government
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This study is aimed to validate the existing stroke risk stratification model for patients with atrial fibrillation (AF) (CHA2DS2-VASc Score, CHADS2 Score, ATRIA score, ABC score, etc.) and establish a new stroke risk assessment model using a nationwide AF -specific registry in China.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * 18 years of age or older; male or female. * History of documented atrial fibrillation. * Able to provide written informed consent. Exclusion Criteria: * Subjects with moderate or severe mitral stenosis or a mechanical heart valve * Subjects with previous or planned AF ablati…
Contacts

Zhe Zheng, MD, PhD

+86-010-88396051

zhengzhe@fuwai.com

CONTACT

Shuo Yuan, MD

yuanshuo@fuwai.com

CONTACT